Kazazian Asset Management, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Kazazian Asset Management, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2019$586,000
+58.0%
3,479
-8.8%
0.81%
+62.5%
Q4 2018$371,000
-51.0%
3,813
-13.0%
0.50%
-29.3%
Q3 2018$757,000
+44.2%
4,385
+16.7%
0.71%
+47.4%
Q2 2018$525,0003,7590.48%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders